Point72 (Difc) LTD Tg Therapeutics, Inc. Transaction History
Point72 (Difc) LTD
- $2.64 Trillion
- Q2 2025
A detailed history of Point72 (Difc) LTD transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Point72 (Difc) LTD holds 3,434 shares of TGTX stock, worth $126,062. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,434Holding current value
$126,062% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding TGTX
# of Institutions
406Shares Held
92.4MCall Options Held
2.28MPut Options Held
1.78M-
Vanguard Group Inc Valley Forge, PA15.8MShares$580 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$418 Million0.0% of portfolio
-
State Street Corp Boston, MA7.62MShares$280 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.49MShares$128 Million0.01% of portfolio
-
Clearbridge Investments, LLC New York, NY3.05MShares$112 Million0.09% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $5.33B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...